Skip to main content
Fig. 3 | BMC Genomics

Fig. 3

From: Analysis of the genomic sequences and metabolites of Serratia surfactantfaciens sp. nov. YD25T that simultaneously produces prodigiosin and serrawettin W2

Fig. 3

The biological activities of the compounds from YD25T. a The antibacterial activities of the components against M. luteus CGMCC 1.2299; b The antibacterial activities of the components against B. subtilis A47; c The cytotoxicity on Hela and Caco2 cells of sw-5 (serrawettin W2); d The cytotoxicity on nonmalignant cells of sw-5 (serrawettin W2). Numbers show an average of three replications, and error bars show standard errors of the means

Back to article page